Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase
NCT04237337
·
clinicaltrials.gov ↗
UNKNOWN
Status
200000
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Malignant Tumor
Interventions
OTHER:
Exposure to MS drugs
Sponsor
University Hospital, Caen